Secondary Marketplace / Trade Private Companies / Buy and Sell Hippocratic AI Stock
Hippocratic AI Hippocratic AI Stock
$1.64B
Series B Valuation, Jan 2025
Register To Buy and Sell Private Company Shares
For more details on private stock price information, financing and valuation for Hippocratic AI, register or login.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Sign in

Hippocratic AI Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Hippocratic AI Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
01/09/2025 Series B $141MM $xx.xx $1.64B Andreessen Horowitz, General Catalyst, Kleiner Perkins, Nvidia, Premji Invest, Sv Angel, Universal Health Services, Wellspan Health
Price per Share
$xx.xx
Shares Outstanding
10,505,610
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, General Catalyst, Kleiner Perkins, Nvidia, Premji Invest, Sv Angel, Universal Health Services, Wellspan Health
09/19/2024 Series A-2 $1.15MM $xx.xx $500MM 7wire Ventures, Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, Greycroft, Memorial Hermann Health System, Nvidia, Premji Invest, Sv Angel, Universal Health Services, Wellspan Health
Price per Share
$xx.xx
Shares Outstanding
470,024
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Ventures, Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, Greycroft, Memorial Hermann Health System, Nvidia, Premji Invest, Sv Angel, Universal Health Services, Wellspan Health
09/19/2024 Series A-1 $70.24MM $xx.xx $500MM 7wire Ventures, Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, Greycroft, Memorial Hermann Health System, Nvidia, Premji Invest, Sv Angel, Universal Health Services, Wellspan Health
Price per Share
$xx.xx
Shares Outstanding
14,031,721
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Ventures, Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, Greycroft, Memorial Hermann Health System, Nvidia, Premji Invest, Sv Angel, Universal Health Services, Wellspan Health
07/25/2023 Series Seed-1 $61.27MM $xx.xx $349.15MM Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, Universal Health Services, Wellspan Health
Price per Share
$xx.xx
Shares Outstanding
21,079,015
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Cincinnati Children's Hospital Medical Center, General Catalyst, Universal Health Services, Wellspan Health
05/16/2023 Series Seed-2 $3.5MM $xx.xx $14.02MM Andreessen Horowitz, General Catalyst
Price per Share
$xx.xx
Shares Outstanding
20,962,918
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, General Catalyst
Company Details
Hippocratic AI is a patient-facing healthcare application language model dedicated to building Health General Intelligence (HGI) with a focus on safety, aiming to address the global shortfall of healthcare workers. The company’s mission is to expand healthcare access and improve the efficiency of healthcare professionals, ensuring evidence-based practice and prioritizing patient safety. Hippocratic AI was founded by Alex Miller, Munjal Shah, and Vishal Parikh in 2022 and is headquartered in San Francisco, CA.
Founded
2022
Post-Money Valuation 3
$1.64B
Total Funding
$277.17MM
LFR Price per Share
$xx.xx
Last Funding Share Class
Series B
Hippocratic AI Stock FAQs
To buy and sell Hippocratic AI stock
Can you buy Hippocratic AI stock?
As Hippocratic AI is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Hippocratic AI, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
How to buy Hippocratic AI stock?

To invest in a private company like Hippocratic AI through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
Can you sell Hippocratic AI stock?
Yes, you may sell the Hippocratic AI stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
How to sell Hippocratic AI stock?

If you hold private company shares of Hippocratic AI – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Hippocratic AI on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
To learn more about Hippocratic AI stock
Is Hippocratic AI a public company?
No, Hippocratic AI is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
What is Hippocratic AI’s stock price?
Hippocratic AI is a privately held company and therefore does not have a public stock price. However, you may access Hippocratic AI private market stock price with Forge Data.
What is Hippocratic AI’s stock ticker symbol?
Hippocratic AI does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Hippocratic AI Investors Also Invested in These Private Companies

Leadership & Board

Leadership

Munjal Shah
Co-Founder
Alex Miller
Co-Founder
Saad Godil
Co-Founder
Subho Mukherjee Ph.D
Co-Founder
Debajyoti Datta
Co-Founder
Vishal Parikh Ph.D
Co-Founder
Paul Gamble MD
Co-Founder
Kim Parikh
Co-Founder
Meenesh Bhimani MD
Co-Founder

Hippocratic AI News and Media Highlights

Hippocratic AI secures $141m in Series B funding

Healthcare-focused AI startup Hippocratic AI has closed its Series B financing round, raising $141m, led by venture capital firm Kleiner Perkins. The funding round, which propelled the firm’s valuation to $1.64bn, comes nine months after the completion of its Series A round.

Hippocratic AI and Adtalem Forms Innovative Partnership to Advance Healthcare Education

Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced that it partnered with Adtalem Global Education (NYSE: ATGE), the number one provider of healthcare education in the U.S., to develop a comprehensive suite of educational materials to train clinicians on the use of AI in healthcare. This collaboration uniquely integrates nurses’ practical experience with the advanced capabilities of artificial intelligence.

Nvidia announces AI-powered health care 'agents' that outperform nurses — and cost $9 an hour

High-powered chipmaker Nvidia has teamed up with artificial intelligence health care company Hippocratic AI to develop generative AI "agents" that not only outperform human nurses on video calls but cost a lot less per hour. The two companies on Thursday announced their collaboration to build "empathetic health care agents" powered by Nvidia and trained on Hippocratic's health care-focused large language model (LLM) that are better able to form a human connection with patients through "super-low latency conversational reactions."

Hippocratic AI banks $53M backed by General Catalyst, a16z, Memorial Hermann, UHS and other health systems

Launched out of stealth about a year ago, Hippocratic AI launched its first generative AI product and pocketed $53 million in series A funding, the startup announced Monday. The fresh funding boosts the company's valuation to $500 million, according to executives. Hippocratic has raised $120 million to date, including a $50 million seed round last May. As AI in healthcare takes off, major investors are placing their bets. Hippocratic is backed by Premji Invest, General Catalyst, SV Angel and Andreessen Horowitz (a16z) Bio + Health. The startup also has a handful of health system investors-- Memorial Hermann Health System, Cincinnati Children’s, WellSpan Health, Universal Health Services (UHS), HonorHealth and OhioHealth.
Browse Insights
Other Companies Like Hippocratic AI in the Healthcare software Sector
Sector: Healthcare
Subsector: Healthcare software
Last Funding Round
Company Forge Price Forge Price Change 5 Last Closed Trade Share Class Post-Money Valuation Price per Share Amount Raised
AbridgeAbridge----$xx.xxSeries D$2.75B$xx.xx$250MM
CedarCedar----$xx.xxSeries D$3.19B$xx.xx$255MM
InnovaccerInnovaccer$7.39+89.49%$xx.xxSeries F-1$3.88B$xx.xx$153.04MM
Insilico MedicineInsilico Medicine----$xx.xx--------
Maze TherapeuticsMaze Therapeutics----$xx.xxSeries D$551.86MM$xx.xx$73.3MM
Rad AIRad AI----$xx.xxSeries B-1$276.13MM$xx.xx$33.21MM
SukiSuki----$xx.xxSeries D$283.39MM$xx.xx$50MM
TraceLinkTraceLink----$xx.xxSeries D$657MM$xx.xx$60MM
VinetiVineti----$xx.xxSeries C$216.51MM$xx.xx$60MM
Viz.aiViz.ai----$xx.xxSeries D$1.28B$xx.xx$120MM

Updated on: Jan 17, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.